Loading...
Midatech Pharma plc
MTPH.L•LSE
Healthcare
Biotechnology
£18.00
£17.05(1794.74%)

Midatech Pharma plc (MTPH.L) Balance Sheet Analysis
Midatech Pharma plc (MTPH.L) manages its money wisely, with plenty of N/A and N/A to cover its bills. The company’s long-term debts are manageable, balanced by steady -1095.28%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a cautious position, giving it room to invest, expand, or adapt. For investors, this paints a risky picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan